A review of a landmark clinical trial that suggests the use of ESAs can improve mortality in critically ill patients.







**************************************

Estimated Time to View: 30 minutes
Title: The Use of Erythropoetic-Stimulating Agents (ESAs) in Acute Illness
Author: Nirav Jasani, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2012, Volume 3, Number 4
Disclaimers: None
Resource Type: Video
Recommend to a Colleague/Friend: Roll Over
Review this teaching resource: Click here

**************************************

LEARNING OPTIONS:

To view the interactive video, click here
To view this 720p high-definition video using an iPad or iPhone, see below





Transparent Peer Review



GD Star Rating
loading...



To learn more about our 6-point transparent peer review system, click here



Share

Comments

  • Nephrology On-Demand Plus


    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


    Available_on_the_App_Store_(black)

  • Kidney Konnection


    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
More in General Nephrology (29 of 212 articles)